Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610.
Zhang M, Ho A, Hammond EH, Suzuki Y, Bermudez RS, Lee RJ, Pilepich M, Shipley WU, Sandler H, Khor LY, Pollack A, Chakravarti A. Zhang M, et al. Among authors: khor ly. Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1033-42. doi: 10.1016/j.ijrobp.2008.06.1489. Epub 2008 Oct 30. Int J Radiat Oncol Biol Phys. 2009. PMID: 18977097 Free PMC article.
Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol 9202.
Chakravarti A, DeSilvio M, Zhang M, Grignon D, Rosenthal S, Asbell SO, Hanks G, Sandler HM, Khor LY, Pollack A, Shipley W; Radiation Therapy Oncology Group. Chakravarti A, et al. Among authors: khor ly. J Clin Oncol. 2007 Jul 20;25(21):3082-9. doi: 10.1200/JCO.2006.08.4152. J Clin Oncol. 2007. PMID: 17634487 Free PMC article. Clinical Trial.
Survivin is a potential mediator of prostate cancer metastasis.
Zhang M, Coen JJ, Suzuki Y, Siedow MR, Niemierko A, Khor LY, Pollack A, Zhang Y, Zietman AL, Shipley WU, Chakravarti A. Zhang M, et al. Among authors: khor ly. Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1095-103. doi: 10.1016/j.ijrobp.2009.09.007. Epub 2010 Mar 16. Int J Radiat Oncol Biol Phys. 2010. PMID: 20231071 Free PMC article.
Ki-67 is an independent predictor of metastasis and cause-specific mortality for prostate cancer patients treated on Radiation Therapy Oncology Group (RTOG) 94-08.
Verhoven B, Yan Y, Ritter M, Khor LY, Hammond E, Jones C, Amin M, Bahary JP, Zeitzer K, Pollack A. Verhoven B, et al. Among authors: khor ly. Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):317-23. doi: 10.1016/j.ijrobp.2013.01.016. Epub 2013 Mar 6. Int J Radiat Oncol Biol Phys. 2013. PMID: 23474109 Free PMC article. Clinical Trial.
Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer.
Parker AS, Heckman MG, Wu KJ, Crook JE, Hilton TW, Pisansky TM, Bernard JR, Schild SE, Khor LY, Hammond EH, Pollack A, Buskirk SJ. Parker AS, et al. Among authors: khor ly. Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1364-70. doi: 10.1016/j.ijrobp.2008.12.061. Epub 2009 May 21. Int J Radiat Oncol Biol Phys. 2009. PMID: 19464826
Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02.
Khor LY, Moughan J, Al-Saleem T, Hammond EH, Venkatesan V, Rosenthal SA, Ritter MA, Sandler HM, Hanks GE, Shipley WU, Pollack A. Khor LY, et al. Clin Cancer Res. 2007 Jun 15;13(12):3585-90. doi: 10.1158/1078-0432.CCR-06-2972. Clin Cancer Res. 2007. PMID: 17575222 Free PMC article. Clinical Trial.
46 results